Forwarded from 📡Guardians of Hong Kong
#Newspaper
Chinese media's disclosure that Wuhan Pneumonia vaccine may increase severity retracted in less than a day
(31 Aug) On 30 August, Yicai Media published a report titled "Exclusive evidence: COVID-19 vaccine may cause aggravated immune response". An anonymous expert from the Shanghai Public Health Clinical Center told the media, "our latest study found that ADE [antibody-dependent enhancement] exists and its prevalence is not low. The results of relevant studies are awaiting publication."
The expert admitted, "COVID-19 presents a risk of ADE, which will be a challenge for the vaccine but it will depend on the specific antigen it uses." He also claimed that earlier this month, the Center for Drug Evaluation of the National Medical Products Administration released the "(Preliminary) Guidelines for the Clinical Evaluation of Prophylactic COVID-19 vaccination", which did not mention the risk of ADE in vaccines. The reality is that many countries have continually deliberated on the ADE issue in COVID-19. As of yet, no in-depth studies exist in the world. He is unsure if his team's findings will be published in peer-reviewed journals. The report from Yicai Media was deleted a day after [its publication].
ADE is the acronym for "antibody-dependent enhancement". The presence of ADE means that after inoculation, the immune response in a portion of the population would exacerbate the disease. As the second wave of the Wuhan Pneumonia sweeps the globe, a man from Reno*, Nevada in the US is re-infected with symptoms much worse than the first time. Although it is still uncertain whether the "ADE phenomenon" caused it, scientists warn that if the Wuhan Pneumonia virus produces ADE, the mortality risk of the second wave will be much higher.
Editor's Note:
* The original article incorrectly states that the man's name is Reno.
Source: Itn
#ADE #ChineseVaccine #Coronavirus
Chinese media's disclosure that Wuhan Pneumonia vaccine may increase severity retracted in less than a day
(31 Aug) On 30 August, Yicai Media published a report titled "Exclusive evidence: COVID-19 vaccine may cause aggravated immune response". An anonymous expert from the Shanghai Public Health Clinical Center told the media, "our latest study found that ADE [antibody-dependent enhancement] exists and its prevalence is not low. The results of relevant studies are awaiting publication."
The expert admitted, "COVID-19 presents a risk of ADE, which will be a challenge for the vaccine but it will depend on the specific antigen it uses." He also claimed that earlier this month, the Center for Drug Evaluation of the National Medical Products Administration released the "(Preliminary) Guidelines for the Clinical Evaluation of Prophylactic COVID-19 vaccination", which did not mention the risk of ADE in vaccines. The reality is that many countries have continually deliberated on the ADE issue in COVID-19. As of yet, no in-depth studies exist in the world. He is unsure if his team's findings will be published in peer-reviewed journals. The report from Yicai Media was deleted a day after [its publication].
ADE is the acronym for "antibody-dependent enhancement". The presence of ADE means that after inoculation, the immune response in a portion of the population would exacerbate the disease. As the second wave of the Wuhan Pneumonia sweeps the globe, a man from Reno*, Nevada in the US is re-infected with symptoms much worse than the first time. Although it is still uncertain whether the "ADE phenomenon" caused it, scientists warn that if the Wuhan Pneumonia virus produces ADE, the mortality risk of the second wave will be much higher.
Editor's Note:
* The original article incorrectly states that the man's name is Reno.
Source: Itn
#ADE #ChineseVaccine #Coronavirus
自由時報電子報
中媒爆接種武肺疫苗或致病症加重 不到1天被下架 - 國際 - 自由時報電子報
武漢肺炎(新型冠狀病毒病,COVID-19)疫情全球爆發,各國無不加速研發疫苗的腳步,日前中國宣布該國已有進入Ⅲ期臨床試驗的疫苗,但昨日有中媒引述上海公共衛生臨床中心專家的話表示,該團隊最新研究發現武漢肺炎恐有「ADE效應」,警告部分人在接種疫苗之後,其自身的免疫反應反而會導致疾病加重,並說中國官方先前公布的疫苗指南未提到此事。原報導不到1日就被刪除。中媒《第一財經》30日刊出,標題為「獨家求證:新冠疫苗的免疫反應可能導致病症加重」的報導,一不具名的上海公共衛生臨床中心專家向該媒體透露,「我們的最新研究…